All In Biotech

Drug Trial Radar · NCT07299019

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 990 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

990

Planned (sponsor's estimate)

Start

Mar 23, 2026

Primary completion

Jun 2030

Study completion Jul 2030

Sponsor

Lead sponsor
Zenas BioPharma (USA), LLCIndustry
Sponsor type
Industry
First posted
Dec 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of orelabrutinib compared with placebo in patients with non-active Secondary Progress MS. Patients will be treated for approximately 24 to 60 months, with a minimum treatment duration of 12 months. The study will enroll approximately 990 subjects in a 2:1 randomization (orelabrutinib: placebo), globally.

Conditions

  • Secondary Progressive Multiple Sclerosis

Interventions

  • OrelabrutinibDrug

    Orelabrutinib orally

  • PlaceboDrug

    Placebo orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to onset of confirmed disability progression (CDP) events, confirmed over at least 24 weeksTime frame: Up to approximately 120 weeks

Locations

98 sites in 20 countries. Site status is shown where the registry gives one.

  • Arizona Neuroscience Research, LLC

    Phoenix, Arizona · Recruiting

  • Perseverance Research Center, LLC (PRC)

    Scottsdale, Arizona · Recruiting

  • Fullerton Neurology and Headache Center

    Fullerton, California · Recruiting

  • Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed))

    Torrance, California · Recruiting

  • Regina Berkovich MD, PhD Inc

    West Hollywood, California · Recruiting

  • SFM Clinical Research, LLC

    Boca Raton, Florida · Recruiting

  • Nova Clinical Research, LLC

    Bradenton, Florida · Recruiting

  • MS and Neuromuscular Center of Excellence

    Clearwater, Florida · Recruiting

  • Neurology Associates

    Maitland, Florida · Recruiting

  • Aqualane Clinical Research

    Naples, Florida · Recruiting

  • University of South Florida Department of Neurology - MS Division

    Tampa, Florida · Recruiting

  • Josephson Wallack Munshower Neurology, Pc Suite 225

    Indianapolis, Indiana · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • KC Research Center, PA Neurology Research Dept

    Roeland Park, Kansas · Recruiting

  • Boston Clinical Trials

    Boston, Massachusetts · Withdrawn

  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts · Recruiting

  • Profound Research LLC at Oakland Neurology Center

    Rochester Hills, Michigan · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • University Of New Mexico School Of Medicine

    Albuquerque, New Mexico · Recruiting

  • Mount Sinai Medical Center

    New York, New York · Recruiting

  • The Ohio State University Wexner Medical Center (OSUWMC)

    Columbus, Ohio · Recruiting

  • The Boster Center for Multiple Sclerosis

    Columbus, Ohio · Recruiting

  • OMRF Multiple Sclerosis Center of Excellence

    Oklahoma City, Oklahoma · Recruiting

  • Premier Neurology

    Greenville, South Carolina · Recruiting

  • Neurology Clinic, P.C.

    Cordova, Tennessee · Recruiting

  • Lone Star Neurology

    San Antonio, Texas · Recruiting

  • Texas Institute for Neurological Disorders - Sherman

    Sherman, Texas · Recruiting

  • Southern Neurology Suite 2

    Kogarah, New South Wales, Australia · Recruiting

  • DCC Neoclinic - Sofia

    Sovet, Belgium · Recruiting

  • MS-Netwerk Limburg - Revalidatie

    Overpelt, Limburg, Belgium · Recruiting

  • Avis Medica Hospital Pleven

    Pleven, Bulgaria · Recruiting

  • Medical Center Nevrocentrum

    Plovdiv, Plovdiv, Bulgaria · Recruiting

  • Medical Center Hera EOOD

    Sofia, Sofia, Bulgaria · Recruiting

  • Diagnostic and Consultative Center Convex

    Sofia, Sofia, Bulgaria · Recruiting

  • Medical Center Medica Plus OOD

    Veliko Tarnovo, Tarnovo, Bulgaria · Recruiting

  • Klinicki Bolnicki Centar Zagreb-Rebro

    Zagreb, Croatia · Recruiting

  • NEUROHK, s.r.o.

    Choceň, Czechia · Recruiting

  • Regional Hospital Jihlava

    Jihlava, Czechia · Recruiting

  • Astra clinic (Clinic4U)

    Tallinn, Harju, Estonia · Recruiting

  • CHU Brest Hospital Cavale

    Pordic, Brest, France · Recruiting

Showing 40 of 98 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.